PRUCALOPRIDE MedTAS prucalopride (as succinate) 2 mg film-coated tablet blister pack

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

prucalopride succinate, Quantity: 2.64 mg (Equivalent: prucalopride, Qty 2 mg)

Dostupno od:

MedTAS Pty Ltd

Farmaceutski oblik:

Tablet, film coated

Sastav:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; triacetin; iron oxide yellow; iron oxide red; macrogol 3000; indigo carmine aluminium lake

Administracija rute:

Oral

Jedinice u paketu:

28 film-coated tablets

Tip recepta:

(S4) Prescription Only Medicine

Terapijske indikacije:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief. ? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation. ? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Proizvod sažetak:

Visual Identification: Pink, round biconvex, film coated tablets debossed with P2 on one side and no debossing on the other side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Status autorizacije:

Registered

Datum autorizacije:

2022-09-12